Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.7935 | 33 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.76546 | 34 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.77155 | 34 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.71533 | 34 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.73514 | 34 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.82286 | 33 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.88142 | 36 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.7392 | 33 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.74423 | 34 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.7564 | 34 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.75189 | 33 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.7082 | 33 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.76517 | 34 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.75167 | 33 |